Standout Papers

Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, mul... 2016 2026 2019 2022 323
  1. Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial (2016)
    David Planchard, Tae Min Kim et al. The Lancet Oncology

Immediate Impact

2 by Nobel laureates 13 from Science/Nature 71 standout
Sub-graph 1 of 21

Citing Papers

Molecular mechanisms of gasdermin D pore-forming activity
2023 Standout
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
2023 Standout

Works of Bo Ma being referenced

Duck gasdermin E is a substrate of caspase-3/-7 and an executioner of pyroptosis
2023
Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial
2016 Standout

Author Peers

Author Last Decade Papers Cites
Bo Ma 1117 914 635 646 81 2.2k
Hernán Carol 1652 946 394 544 92 2.9k
Peter J. Dawson 607 945 415 454 61 2.2k
William McCulloch 1325 477 494 222 82 2.4k
Stuart A.C. McDonald 1134 894 688 589 61 3.0k
David Tulasne 1294 445 265 432 73 2.4k
Xing Huang 1561 1101 626 419 105 3.0k
Marcus Mareel 883 583 310 158 88 1.7k
Duane H. Hamilton 714 1188 334 438 48 2.2k
Jerald J. Killion 1495 1205 707 700 66 3.1k
Rainer Engers 1586 830 613 574 65 2.7k

All Works

Loading papers...

Rankless by CCL
2026